Back to search

University of British Columbia

Oncofetal chondroitin sulfate as a target in solid tumors

Abstract

dc:description

The malaria parasite Plasmodium falciparum expresses VAR2CSA proteins on the surface of infected red blood cells that bind a distinct type of chondroitin sulfate (CS) glycosaminoglycan (GAG) exclusively present in the placenta. This interaction is the key underlying cause of pregnancy-associated malaria outbreaks in endemic regions of the world. Interestingly, placental-type CS GAGs become re-expressed in multiple human cancers as a secondary oncofetal CS (ofCS) modification to proteoglycans. I used this specific feature of malaria tropism to develop novel cancer diagnostic and therapeutic strategies. By incorporating the recombinant VAR2CSA protein (rVAR2) sequence into a chimeric antigen receptor (CAR), I was able to develop a universal anti-ofCS CAR (VAR2-CAR) with affinity for tumor cells expressing ofCS. In order to obtain a strong safety profile, I designed a switch-CAR system in which a non-binding CAR could be secondarily ‘armed’ with a rVAR2-switch molecule producing functional ofCS-reactive sVAR2-CAR T cells. The population of armed CAR T cells was controlled by the concentration of the switch molecule and importantly, halting the addition of the switch molecule through clonal expansion, cleared the armed population of sVAR2-CAR T cells from the organism post-treatment. Co-culturing the sVAR2-CAR T cells with human tumor cells resulted in activation of the CAR T cells as assessed by expression of activation markers and production of cytokines. The sVAR2-CAR T cells were able to engage diverse ofCS-positive tumor cells and effectively eliminate them. Finally, two treatments of sVAR2-CAR T cells were able to markedly decrease tumor burden in a murine xenograft model of bladder cancer. My data provide proof-of-concept for an rVAR2-armed CAR-T cell approach to treat ofCS-positive cancers. In addition, ofCS is an efficient and specific target for isolating tumor cells from blood samples. A variety of ofCS positive cancer cells spiked into the blood were successfully isolated by employing rVAR2-coated magnetic beads. Combining rVAR2-technology and nucleic acid detection, I was able to develop a new strategy for isolating and identifying circulating tumor cells (CTC). Taken together, the exclusive expression of ofCS on tumors and the high specificity of rVAR2 to ofCS, can be complementary exploited for tumor diagnosis and treatment.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • khazamipour, Nastaran
Contributors dc:contributor
  • Daugaard, Mads

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/80039

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

khazamipour, Nastaran. Oncofetal chondroitin sulfate as a target in solid tumors. doctoral thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/80039